XML 151 R137.htm IDEA: XBRL DOCUMENT v3.22.0.1
Parent Company Only Condensed Financial Information - Condensed Parent Company Only Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Net income $ 112,974 $ 64,024 $ 58,544
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Net accretion of securities (992) (129) 205
Amortization of junior subordinated debentures 530 506 483
Amortization of subordinated notes issuance costs 1,224 182 116
Stock based compensation 20,315 4,618 3,654
Change in other assets (8,684) 12,215 (14,991)
Net cash provided by (used in) operating activities 136,959 97,327 72,450
Cash flows from investing activities:      
Proceeds from maturities, calls, and pay downs of securities held to maturity 1,003 693 993
Net cash provided by (used in) investing activities 77,656 (774,737) (520,372)
Cash flows from financing activities:      
Proceeds from issuance of subordinated notes, net 68,224 0 38,282
Repayment of subordinated notes (50,000) 0 0
Issuance of common stock, net of issuance costs 0 0 0
Issuance of preferred stock, net of issuance costs 0 42,364 0
Dividends on preferred stock (3,206) (1,701) 0
Purchase of treasury stock (1,241) (35,772) (64,524)
Stock option exercises 577 (227) 0
Proceeds from employee stock purchase plan common stock issuance 449 0 0
Net cash provided by (used in) financing activities (145,830) 793,923 410,863
Net increase (decrease) in cash and cash equivalents 68,785 116,513 (37,059)
Cash and cash equivalents at end of period 383,178 314,393 197,880
Cash and cash equivalents at beginning of period 314,393 197,880 234,939
Parent Company      
Cash flows from operating activities:      
Net income 112,974 64,024 58,544
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Equity in undistributed subsidiary income (121,892) (58,501) (35,938)
Net accretion of securities (87) (221) (923)
Amortization of junior subordinated debentures 530 506 483
Amortization of subordinated notes issuance costs 1,224 182 116
Stock based compensation 420 315 315
Credit loss expense (benefit) 56 1,900 0
Change in other assets 387 337 2,438
Change in accrued expenses and other liabilities 546 505 (4,771)
Net cash provided by (used in) operating activities (5,842) 9,047 20,264
Cash flows from investing activities:      
Investment in subsidiaries 3,383 146 0
Proceeds from maturities, calls, and pay downs of securities held to maturity 1,003 693 993
Net change in loans 0 719 9,193
Net cash provided by (used in) investing activities 4,386 1,558 10,186
Cash flows from financing activities:      
Proceeds from issuance of subordinated notes, net 68,224 0 38,282
Repayment of subordinated notes (50,000) 0 0
Issuance of common stock, net of issuance costs 0 0 0
Issuance of preferred stock, net of issuance costs 0 42,364 0
Dividends on preferred stock (3,206) (1,701) 0
Purchase of treasury stock (1,241) (35,772) (64,524)
Stock option exercises 577 (227) 0
Proceeds from employee stock purchase plan common stock issuance 449 0 0
Net cash provided by (used in) financing activities 14,803 4,664 (26,242)
Net increase (decrease) in cash and cash equivalents 13,347 15,269 4,208
Cash and cash equivalents at end of period 64,530 51,183 35,914
Cash and cash equivalents at beginning of period $ 51,183 $ 35,914 $ 31,706